Potential Effect of Curcumin versus Atorvastatin on Hepatic and Metabolic Changes in Rat Model of Metabolic Syndrome
Background: Metabolic syndrome is defined as a cluster of metabolic disorders, including hypertension, insulin resistance, dyslipidemia, diabetes, cardiovascular disease and abdominal [central] obesity. It is also found under different names, such as syndrome X, “deadly quartet” and insulin resistan...
Guardado en:
Autores principales: | Alaaeldin Eissa, Abdelateef Abdelateef, Hassan Elkotby |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Al-Azhar University, Faculty of Medicine (Damietta)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ac5af370f0a4cea866978f50cc91a0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis
por: Li X, et al.
Publicado: (2019) -
EFFECTS OF AN EIGHT-WEEK ATORVASTATIN TREATMENT ON SPONTANEOUS CYTOKINE PRODUCTION BY THE BLOOD MONONUCLEAR LEUKOCYTES IN METABOLIC SYNDROME
por: I. D. Bespalovа, et al.
Publicado: (2014) -
Atorvastatin Has no Effects on Kidney Tissues of Wistar Albino Rats in the Long-Term Intake: An Electron Microscopic Study
por: Aktas,Ayfer, et al.
Publicado: (2011) -
A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy
por: Gellért Balázs Karvaly, et al.
Publicado: (2021) -
Atorvastatin-Medicated Dentifrice Significantly Inhibits CD4+ T Cell Proliferation: In vitro Pilot Study
por: Rosenberg,David R, et al.
Publicado: (2017)